Table 3.
Inhibitor | Phase | Company | References |
---|---|---|---|
CH5424802 | II | Chugai | 93,94 |
LDK378 | I | Novartis | 95 |
ASP3026 | I | Astellas Pharma | 100 |
AP26113 | I/II | Ariad | 98 |
X396 | I | Xcovery | 99 |
Inhibitor | Phase | Company | References |
---|---|---|---|
CH5424802 | II | Chugai | 93,94 |
LDK378 | I | Novartis | 95 |
ASP3026 | I | Astellas Pharma | 100 |
AP26113 | I/II | Ariad | 98 |
X396 | I | Xcovery | 99 |